Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group [REVIEW ARTICLE]
Conclusion
The International Bladder Cancer Group has developed formal recommendations regarding definitions, end points, and clinical trial designs for NMIBC to encourage uniformity among studies in this disease.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Kamat, Sylvester, Bohle, Palou, Lamm, Brausi, Soloway, Persad, Buckley, Colombel, Witjes Tags: Clinical Trials, Chemotherapy, Combined Modality Therapy REVIEW ARTICLE Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | Clinical Trials | Study | Toxicology